Who owns Spero Therapeutics Inc?
- Ticker: SPRO
- CUSIP Number: 84833t103
Tip: Access positions for across all investors
Analyze quarterly positions in Spero Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Spero Therapeutics stock
Who bought or sold Spero Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.7M | $2.8M | 1% | Mar 2024 |
|
| ADAR1 Capital Management | 927k | $1.6M | -13% | Mar 2024 |
|
| Alphabet | 890k | $1.5M | 0% | Mar 2024 |
|
| Murchinson | 874k | $1.5M | 1% | Mar 2024 |
|
| Acadian Asset Management | 763k | $1.3M | 180% | Mar 2024 |
|
| Atlas Venture Life Science Advisors | 608k | $1.0M | -40% | Mar 2024 |
|
| BlackRock | 477k | $820k | -1% | Mar 2024 |
|
| Geode Capital Management | 469k | $808k | 14% | Mar 2024 |
|
| AWM Investment Company | 333k | $573k | 0% | Mar 2024 |
|
| Shay Capital | 307k | $528k | 100% | Mar 2024 |
|
| Man Group | 214k | $368k | 100% | Mar 2024 |
|
| Bridgeway Capital Management | 185k | $318k | 37% | Mar 2024 |
|
| Millennium Management | 148k | $254k | -1% | Mar 2024 |
|
| DAFNA Capital Management | 125k | $215k | 0% | Mar 2024 |
|
| Northern Trust | 115k | $197k | 29% | Mar 2024 |
|
| Bank Of Montreal | 80k | $140k | 100% | Mar 2024 |
|
| Squarepoint Ops | 79k | $137k | -35% | Mar 2024 |
|
| Bailard | 61k | $105k | 100% | Mar 2024 |
|
| DLK Investment Management | 31k | $54k | 0% | Mar 2024 |
|
| Charles Schwab Investment Management | 29k | $49k | 0% | Mar 2024 |
|
| Mackenzie Financial | 28k | $49k | 33% | Mar 2024 |
|
| GSA Capital Partners | 28k | $49k | 100% | Mar 2024 |
|
| Susquehanna International | 20k | $34k | -3% | Mar 2024 |
|
| Virtu Financial | 18k | $31k | 100% | Mar 2024 |
|
| XTX Topco | 15k | $26k | -74% | Mar 2024 |
|
| Dimensional Fund Advisors | 10k | $17k | 0% | Mar 2024 |
|
| Yale Capital Corp. | 10k | $17k | 0% | Mar 2024 |
|
| Morgan Stanley | 7.9k | $13k | -12% | Mar 2024 |
|
| Russell Investments | 6.4k | $11k | 0% | Mar 2024 |
|
| UBS Group | 5.7k | $9.9k | 1641% | Mar 2024 |
|
| Bank of America Corporation | 5.2k | $8.9k | -10% | Mar 2024 |
|
| FMR | 2.4k | $4.1k | 100% | Mar 2024 |
|
| Hanson McClain Advisors | 600.00 | $1.0k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 540.00 | $928.800000 | 1% | Mar 2024 |
|
| Raleigh Capital Management | 500.00 | $860.000000 | 100% | Mar 2024 |
|
| Rhumbline Advisers | 458.00 | $786.981400 | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 236.00 | $405.990800 | 0% | Mar 2024 |
|
| Tower Research Capital | 216.00 | $371.995200 | -62% | Mar 2024 |
|
| Us Bancorp | 151.00 | $260.006900 | 0% | Mar 2024 |
|
| Goss Wealth Management | 100.00 | $172.000000 | 0% | Mar 2024 |
|
| PFS Partners | 50.00 | $86.000000 | 0% | Mar 2024 |
|
| Advisor Group Holdings | 47.00 | $80.999800 | -52% | Mar 2024 |
|
| Federation des caisses Desjardins du Quebec | 30.00 | $51.999000 | 100% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 12.00 | $21.000000 | 0% | Mar 2024 |
|
| Qube Research & Technologies | 1.00 | $2.000000 | 0% | Mar 2024 |
|
Who sold out of Spero Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Ameriprise Financial | Sep 2023 | 464k | $561k |
| Rock Springs Capital Management | Sep 2023 | 57k | $69k |
| Group One Trading | Sep 2023 | 34k | $41k |
| Citadel Advisors | Dec 2023 | 32k | $47k |
| Bourgeon Capital Management | Dec 2023 | 15k | $22k |
| Two Sigma Securities | Dec 2023 | 10k | $15k |
| Royal Bank of Canada | Dec 2023 | 315.00 | $0 |